The enhancement of humoral and cellular immune responses by dimethyldioctadecylammonium bromide.
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000941:Antigens / Q000008:administration & dosage; D001202:Ascitic Fluid / Q000166:cytology; D002449:Cell Aggregation / Q000187:drug effects; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006460:Hemolysin Proteins; D006462:Hemolytic Plaque Technique; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects*; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007376:Interleukin-2 / Q000096:biosynthesis; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012756:Sheep
D000276:Adjuvants, Immunologic; D000941:Antigens; D006460:Hemolysin Proteins; D007376:Interleukin-2; D000644:Quaternary Ammonium Compounds; C015831:dimethyldioctadecylammonium